BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 15196302)

  • 1. LY293558, a novel AMPA/GluR5 antagonist, is efficacious and well-tolerated in acute migraine.
    Sang CN; Ramadan NM; Wallihan RG; Chappell AS; Freitag FG; Smith TR; Silberstein SD; Johnson KW; Phebus LA; Bleakman D; Ornstein PL; Arnold B; Tepper SJ; Vandenhende F
    Cephalalgia; 2004 Jul; 24(7):596-602. PubMed ID: 15196302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two replicate randomized, double-blind, placebo-controlled trials of the time to onset of pain relief in the acute treatment of migraine with a fast-disintegrating/rapid-release formulation of sumatriptan tablets.
    Sheftell FD; Dahlöf CG; Brandes JL; Agosti R; Jones MW; Barrett PS
    Clin Ther; 2005 Apr; 27(4):407-17. PubMed ID: 15922814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of sumatriptan tablets in migraineurs self-described or physician-diagnosed as having sinus headache: a randomized, double-blind, placebo-controlled study.
    Ishkanian G; Blumenthal H; Webster CJ; Richardson MS; Ames M
    Clin Ther; 2007 Jan; 29(1):99-109. PubMed ID: 17379050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of the 2-amino-3-hydroxy-5-methyl-4-isoxazole-proprionic acid/kainate antagonist LY293558 on spontaneous and evoked postoperative pain.
    Gilron I; Max MB; Lee G; Booher SL; Sang CN; Chappell AS; Dionne RA
    Clin Pharmacol Ther; 2000 Sep; 68(3):320-7. PubMed ID: 11014414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized, double-blind, placebo-controlled trial of the efficacy and tolerability of a 4-mg dose of subcutaneous sumatriptan for the treatment of acute migraine attacks in adults.
    Wendt J; Cady R; Singer R; Peters K; Webster C; Kori S; Byrd S
    Clin Ther; 2006 Apr; 28(4):517-26. PubMed ID: 16750463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early intervention in migraine with sumatriptan tablets 50 mg versus 100 mg: a pooled analysis of data from six clinical trials.
    Winner P; Landy S; Richardson M; Ames M
    Clin Ther; 2005 Nov; 27(11):1785-94. PubMed ID: 16368449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single-dose intravenous tramadol for acute migraine pain in adults: a single-blind, prospective, randomized, placebo-controlled clinical trial.
    Alemdar M; Pekdemir M; Selekler HM
    Clin Ther; 2007 Jul; 29(7):1441-7. PubMed ID: 17825695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of almotriptan 12.5 mg in achieving migraine-related composite endpoints: a double-blind, randomized, placebo-controlled study in patients controlled study in patients with previous poor response to sumatriptan 50 mg.
    Diener HC
    Curr Med Res Opin; 2005 Oct; 21(10):1603-10. PubMed ID: 16238900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized, multicenter trial to assess the efficacy, safety and tolerability of a single dose of a novel AMPA receptor antagonist BGG492 for the treatment of acute migraine attacks.
    Gomez-Mancilla B; Brand R; Jürgens TP; Göbel H; Sommer C; Straube A; Evers S; Sommer M; Campos V; Kalkman HO; Hariry S; Pezous N; Johns D; Diener HC;
    Cephalalgia; 2014 Feb; 34(2):103-13. PubMed ID: 23963355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral sumatriptan for the acute treatment of probable migraine: first randomized, controlled study.
    Tepper SJ; Cady R; Dodick D; Freitag FG; Hutchinson SL; Twomey C; Kuhn TA
    Headache; 2006 Jan; 46(1):115-24. PubMed ID: 16412159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sumatriptan and naproxen sodium for the acute treatment of migraine.
    Smith TR; Sunshine A; Stark SR; Littlefield DE; Spruill SE; Alexander WJ
    Headache; 2005 Sep; 45(8):983-91. PubMed ID: 16109111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Almotriptan in migraine patients who respond poorly to oral sumatriptan: a double-blind, randomized trial.
    Diener HC; Gendolla A; Gebert I; Beneke M
    Headache; 2005; 45(7):874-82. PubMed ID: 15985104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sumatriptan nasal spray in adolescent migraineurs: a randomized, double-blind, placebo-controlled, acute study.
    Winner P; Rothner AD; Wooten JD; Webster C; Ames M
    Headache; 2006 Feb; 46(2):212-22. PubMed ID: 16492230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of menstruation-associated migraine headache with subcutaneous sumatriptan.
    Solbach MP; Waymer RS
    Obstet Gynecol; 1993 Nov; 82(5):769-72. PubMed ID: 8414324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AMPA/kainate antagonist LY293558 reduces capsaicin-evoked hyperalgesia but not pain in normal skin in humans.
    Sang CN; Hostetter MP; Gracely RH; Chappell AS; Schoepp DD; Lee G; Whitcup S; Caruso R; Max MB
    Anesthesiology; 1998 Nov; 89(5):1060-7. PubMed ID: 9821993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Valdecoxib for treatment of a single, acute, moderate to severe migraine headache.
    Kudrow D; Thomas HM; Ruoff G; Ishkanian G; Sands G; Le VH; Brown MT
    Headache; 2005 Oct; 45(9):1151-62. PubMed ID: 16178945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Placebo-controlled comparison of effervescent acetylsalicylic acid, sumatriptan and ibuprofen in the treatment of migraine attacks.
    Diener HC; Bussone G; de Liano H; Eikermann A; Englert R; Floeter T; Gallai V; Göbel H; Hartung E; Jimenez MD; Lange R; Manzoni GC; Mueller-Schwefe G; Nappi G; Pinessi L; Prat J; Puca FM; Titus F; Voelker M;
    Cephalalgia; 2004 Nov; 24(11):947-54. PubMed ID: 15482357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A clinical trial of trimethobenzamide/diphenhydramine versus sumatriptan for acute migraines.
    Friedman BW; Hochberg M; Esses D; Bijur PE; Corbo J; Paternoster J; Solorzano C; Toosi B; Lipton RB; Gallagher EJ
    Headache; 2006 Jun; 46(6):934-41. PubMed ID: 16732839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fixed-dose sumatriptan and naproxen in poor responders to triptans with a short half-life.
    Mathew NT; Landy S; Stark S; Tietjen GE; Derosier FJ; White J; Lener SE; Bukenya D
    Headache; 2009 Jul; 49(7):971-82. PubMed ID: 19486178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A double-blind placebo-controlled study assessing the efficacy and tolerability of 50 mg sumatriptan tablets in the acute treatment of migraine. Sumatriptan Tablets S2CM07 Study Group.
    Savani N; Brautaset NJ; Reunanen M; Szirmai I; Ashford EA; Hassani H; Saiers J
    Int J Clin Pract Suppl; 1999 Aug; 105():7-15. PubMed ID: 10692717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.